Home / Resource Library / Pan-Phosphatidylinositol 3-Kinase Inhibition With Buparlisib In Patients With Relapsed Or Refractory Non-Hodgkin Lymphoma

Pan-Phosphatidylinositol 3-Kinase Inhibition With Buparlisib In Patients With Relapsed Or Refractory Non-Hodgkin Lymphoma

Results of a phase II study involving Buparlisib for relapsed B-cell lymphoma.